Impax Laboratories, Inc.
IPXL
IPXL was delisted on the 4th of May, 2018.
149 hedge funds and large institutions have $1.12B invested in Impax Laboratories, Inc. in 2013 Q2 according to their latest regulatory filings, with 149 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
47% less call options, than puts
Call options by funds: $3.82M | Put options by funds: $7.28M
Top Buyers
Top Sellers
IPXL Hedge Fund Activity: Q2 2013 in Review
149 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Impax Laboratories, Inc. (IPXL) for Q2 2013, worth a combined $1.12B.
Buyers outnumbered sellers: 149 funds opened new IPXL positions and 0 closed out — a net gain of 149 holders — while 0 added to existing stakes and 0 trimmed.
- 149 institutional investors held Impax Laboratories, Inc. (IPXL) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $1.12B of Impax Laboratories, Inc. stock for Q2 2013.
- 149 funds opened new Impax Laboratories, Inc. positions in Q2 2013 and 0 closed out, a net change of +149 holders.
Based on aggregated 13F filings for Q2 2013.